Plasma Fractionation Market - By Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others) By Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, Others) By End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, Others) By Region (North America, Europe, Asia Pacific, Rest of the World, Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 189
Status: Published
Report Code: ARI100748
Plasma is a blood component, derived from whole blood by plasmapheresis, and used for various therapeutic and medical applications. Human plasma is a source of numerous different proteins, however only few of these proteins are useful for producing therapeutic plasma products. The process of separation, extraction and purification of these proteins from the plasma is called as fractionation process. The proteins extracted from the plasma are mainly categorized into three main classes: immunoglobulins which are useful in treatment of autoimmune diseases and increasing the immune response, clotting factors which are used in treatment of blood disorders such as haemophilia and lastly the albumins which are useful in cases of depleted albumin levels or during fluid loss. Plasma fractionation process is mainly based upon different criteria such as solubility of the products, and their physical and chemical conditions such as pH levels, ionic strengths, and temperature, etc. The derived plasma products, also known as Fresh Frozen Plasma (FFP) are then subjected to various mechanical and physical treatments for virus inactivation such as Nano filtration, detergent/solvent treatment, heat treatment, chromatography centrifugation, ultrafiltration and sterile filtration in order to achieve homogeneity of plasma derived from numerous donors and reduce the risks of viral transmissions. The global market for plasma fractionation is expected to be driven by increasing incidences of blood and immune disorders owing to increasing aging population, along with increasing off-label usage of critical plasma products such as albumins, and immunoglobulin’s. According to Centres of Disease Control (CDC), in 2012 chronic diseases were one of the leading causes of death and disability in the U.S., with an estimated 117 Mn adults suffering from some form of chronic disease. Improved diagnostic facilities, and ease of access to healthcare along with increasing incidences and prevalence of chronic diseases around the world, are some factors responsible for the rising demand for plasma derived products and is expected to drive the plasma fractionation market during the forecast period of 2016-2024. However, escalating costs of plasma derivatives and the risk factors associated with them, combined with increasing usage of recombinant proteins and products acting as a substitute for the plasma products are expected to restrain the growth of the global plasma fractionation market during the forecast period.
Major players in the global plasma fractionation industry include CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), BPL (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), Green Cross Corporation (South Korea), and Shanghai RAAS Blood Products (China). Geographic expansions and collaborations are the key strategies undertaken by these companies to maintain their positions in the market.
Analyst Commentary
The growth of the plasma fractionation market can be attributed to the factors such as a rise in the use of prophylactic treatment for immune & bleeding diseases and increased diagnosis rate worldwide. Ongoing growth in geriatric population and increasing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases is likely to contribute to the growth of the global plasma fractionation market.
Among the products segment, Immunoglobulin (IVIG) segment is expected to dominate the global plasma fractionation market during the forecast period, owing to factors such as increasing demand for immunoglobulin products due to rising incidences of immunodeficiency and neurological diseases. Among the applications segment, the neurology diseases segment is expected to account for the largest share in the global plasma fractionation market during the forecast period. Rising incidences of neurological disorders and increasing aging population are factors driving the growth of the neurology segment in the global plasma fractionation market. Among the end users segment, hospitals are expected to dominate the global plasma fractionation market, due to improving infrastructure, and healthcare facilities provided by hospitals, along with increasing off-label use of plasma fractionated products in hospitals to treat various diseases.
Segmentation
The global plasma fractionation market is segmented based on product, application, end user, and region.The global market for plasma fractionation, by product is segmented into immunoglobulin, coagulation factor concentrates, albumin, protease inhibitors, and others. The immunoglobulin segment is further classified as intravenous immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG), and others. The coagulation factor concentrates segment is further classified as Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, and Factor XIII.Based on application, the market is segmented into immunology, neurology, hematology, critical care, pulmonology, rheumatology, hemato-oncology, and others.Based on end user, the market is segmented into hospitals & clinics, clinical research laboratories, academic institutes, and others.
Regional Analysis
Geographically, the plasma fractionation market has been studied for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the plasma fractionation market during the forecast period. Growth in North America is primarily driven by the growing use of immunoglobulin in various therapeutic areas, growing geriatric population, and the increasing prevalence of respiratory diseases and AATD. Furthermore, several innovations in manufacturing processes (e.g. improvement of yield), product developments (e.g. such as subcutaneous IG, IVIg 10% concentration, and IVIg liquid presentation), presence of advanced virus removal technologies (such as nanofiltration), and the development of newer plasma products such as ceruloplasmin and IgA are also supporting the growth of the plasma fractionation market in these regions.
In the North American region, the United States accounted for the largest market share due to the rising geriatric population and various associated diseases. The Alzheimer's Association stated that around 5.8 million people in the United States are living with Alzheimer’s disease in 2018. This disease is the sixth leading cause of death in the United States and is more prevalent among people above 65 years of age, as approximately 5.6 million patients fall in this age bracket. With the baby-boom generation reaching around 65 years of age, this number is expected to reach 14 million, worsening the situation over the forecast period. By 2050, a new case of the disease is expected to develop every 33 seconds.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Plasma Fractionation Market
Chapter 5. Global Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
5.1. Global Plasma Fractionation Market Share, By Product, 2015 - 2027 (USD Billion)
5.1.1. Immunoglobulin
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Coagulation factor concentrates
5.1.2.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Albumin
5.1.3.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Protease Inhibitors
5.1.4.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.5. Others
5.1.5.1. Market Size and Projections,2015 - 2027 (USD Billion)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
6.1. Global Plasma Fractionation Market Share, By Application, 2015 - 2027 (USD Billion)
6.1.1. Immunology
6.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Neurology
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Hematology
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Critical Care
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.5. Pulmonology
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.6. Rheumatology
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.7. Hemato-Oncology
6.1.7.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.7.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.8. Others
6.1.8.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.8.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Plasma Fractionation Market Overview, By End User, 2015 - 2027(USD Billion)
7.1. Global Plasma Fractionation Market Share, By End User, 2015 - 2027 (USD Billion)
7.1.1. Hospitals & Clinics
7.1.1.1. Market Size and Projections,2015 - 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Clinical Research Laboratories
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.3. Academic Institutes
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Plasma Fractionation Market Overview, By Geography, 2015 - 2027(USD Billion)
8.1. Global Plasma Fractionation Market Share, By Geography, 2015 - 2027(USD Billion)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Plasma Fractionation Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. North America Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.3. North America Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.4. North America Plasma Fractionation Market Overview, By End User, 2015 - 2027 (USD Billion)
9.1.5. North America Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.1.3. U.S. Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.2.3. Canada Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
9.1.5.3.3. Mexico Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.3.4. Other Segment
Chapter 10. Europe Plasma Fractionation Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. Europe Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
10.1.3. Europe Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.4. Europe Plasma Fractionation Market Overview, By End User,2015 - 2027 (USD Billion)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.1.3. Germany Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. France Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.2.3. France Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. UK Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.3.3. UK Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Italy Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.4.3. Italy Plasma Fractionation Market Overview, By Application 2015 - 2027(USD Billion)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
10.1.5.5.2. Spain Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.5.3. Spain Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
10.1.5.6.3. Rest of Europe Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Asia Pacific Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.2. Asia Pacific Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
11.1.3. Asia Pacific Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.4. Asia Pacific Plasma Fractionation Market Overview, By End User,2015 - 2027 (USD Billion)
11.1.5. Asia Pacific Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.5.1.2. India Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.1.3. India Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2027(USD Billion)
11.1.5.2.2. China Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.2.3. China Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.5.3.2. Japan Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.3.3. Japan Plasma Fractionation Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2027(USD Billion)
11.1.5.4.2. South Korea Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.4.3. South Korea Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2027 (USD Billion)
11.1.5.5.2. Rest of Asia Pacific Plasma Fractionation Market Overview, By Product, 2015 - 2027(USD Billion)
11.1.5.5.3. Rest of Asia Pacific Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Middle East & Africa Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.2. Middle East & Africa Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.3. Middle East & Africa Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.4. Middle East & Africa Plasma Fractionation Market Overview, By End User,2015 - 2027 (USD Billion)
12.1.5. Middle East & Africa Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.5.1.2. GCC Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.1.3. GCC Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.5.2.2. South Africa Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.2.3. South Africa Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2027 (USD Billion)
12.1.5.3.2. Rest of Middle East & Africa Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
12.1.5.3.3. Rest of Middle East & Africa Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.3.4. Other Segments
Chapter 13. South America Plasma Fractionation Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. South America Plasma Fractionation Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market Size and projections, 2015 - 2027 (USD Billion)
13.1.2. South America Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.3. South America Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.4. South America Plasma Fractionation Market Overview, By End User,2015 - 2027 (USD Billion)
13.1.5. South America Plasma Fractionation Market Overview, By Countries, 2015- 2026 (USD Billion)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2027 (USD Billion)
13.1.6.2. Brazil Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.6.3. Brazil Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2027 (USD Billion)
13.1.7.2. Argentina Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.7.3. Argentina Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2027
13.1.8.2. Rest of South America Plasma Fractionation Market Overview, By Product, 2015 - 2027 (USD Billion)
13.1.8.3. Rest of South America Plasma Fractionation Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. Grifols
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Shire
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Octapharma
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Kedrion
15.5. BPL
15.6. Sanquin
15.7. LFB
15.8. BIOTEST
15.9. Japan Blood Products Organization
15.10. China Biologic Products
15.11. Others
Chapter 16. Plasma Fractionation Market Cost Analysis
16.1. Plasma Fractionation Market Key Size Analysis
16.1.1. Key Size
16.1.2. Price Trend of Key Size
16.1.3. Key Suppliers of Size
16.1.4. Market Concentration Rate of Size
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Plasma Fractionation Market Chain Analysis
17.2. Upstream Size Sourcing
17.3. Plasma Fractionation Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Plasma Fractionation Market share, By Product, 2020 & 2027 (%)
10. Global Plasma Fractionation Market share, by Immunoglobulin, By Product, 2015 - 2027 (USD Billion)
11. Global Plasma Fractionation Market share, by Coagulation factor concentrates, By Product, 2015 - 2027 (USD Billion)
12. Global Plasma Fractionation Market share, by Albumin, By Product, 2015 - 2027 (USD Billion)
13. Global Plasma Fractionation Market share, by Protease Inhibitors, By Product, 2015 - 2027 (USD Billion)
14. Global Plasma Fractionation Market share, by Others, By Product, 2015 - 2027 (USD Billion)
15. Global Plasma Fractionation Market share, By Application, 2020 & 2027 (%)
16. Global Plasma Fractionation Market share, by Immunology, By Application, 2015 - 2027 (USD Billion)
17. Global Plasma Fractionation Market share, by Neurology, By Application 2015 - 2027 (USD Billion)
18. Global Plasma Fractionation Market share, by Hematology, By Application 2015 - 2027 (USD Billion)
19. Global Plasma Fractionation Market share, by Critical Care, By Application 2015 - 2027 (USD Billion)
20. Global Plasma Fractionation Market share, by Pulmonology, By Application 2015 - 2027 (USD Billion)
21. Global Plasma Fractionation Market share, by Rheumatology, By Application 2015 - 2027 (USD Billion)
22. Global Plasma Fractionation Market share, by Hemato-Oncology, By Application 2015 - 2027 (USD Billion)
23. Global Plasma Fractionation Market share, by Others, By Application 2015 - 2027 (USD Billion)
24. Global Plasma Fractionation Market share, By End User, 2020 & 2027 (%)
25. Global Plasma Fractionation Market share, by Hospitals & Clinics, By End User, 2015 - 2027 (USD Billion)
26. Global Plasma Fractionation Market share, by Clinical Research Laboratories, By End User 2015 - 2027 (USD Billion)
27. Global Plasma Fractionation Market share, by Academic Institutes, By End User 2015 - 2027 (USD Billion)
28. Global Plasma Fractionation Market share, by Others, By End User 2015 - 2027 (USD Billion)
29. Global Plasma Fractionation Market share, by region, 2020 & 2027 (%)
30. Global Plasma Fractionation Market share, by region, 2015 - 2027(USD Billion)
31. North America Plasma Fractionation Market, 2015 - 2027(USD Billion)
32. North America Plasma Fractionation Market share, by Countries, 2020 & 2027 (%)
33. U.S. Plasma Fractionation Market, 2015 - 2027(USD Billion)
34. Canada Plasma Fractionation Market, 2015 - 2027(USD Billion)
35. Mexico Plasma Fractionation Market, 2015 - 2027(USD Billion)
36. Europe Plasma Fractionation Market, 2015 - 2027(USD Billion)
37. Europe Plasma Fractionation Market share, by Countries, 2020 & 2027 (%)
38. Spain Plasma Fractionation Market, 2015 - 2027(USD Billion)
39. UK Plasma Fractionation Market, 2015 - 2027(USD Billion)
40. Italy Plasma Fractionation Market, 2015 - 2027(USD Billion)
41. Germany Plasma Fractionation Market, 2015 - 2027(USD Billion)
42. France Plasma Fractionation Market, 2015 - 2027(USD Billion)
43. Rest of Europe Plasma Fractionation Market, 2015 - 2027(USD Billion)
44. Asia-Pacific Plasma Fractionation Market, 2015 - 2027(USD Billion)
45. Asia-Pacific Plasma Fractionation Market share, by Countries, 2020 & 2027 (%)
46. China Plasma Fractionation Market, 2015 - 2027(USD Billion)
47. India Plasma Fractionation Market, 2015 - 2027(USD Billion)
48. Australia Plasma Fractionation Market, 2015 - 2027(USD Billion)
49. Japan Plasma Fractionation Market, 2015 - 2027(USD Billion)
50. Rest of Asia-Pacific Plasma Fractionation Market, 2015 - 2027(USD Billion)
51. Middle East & Africa Plasma Fractionation Market, 2015 - 2027(USD Billion)
52. Middle East & Africa Plasma Fractionation Market share, by Countries, 2020 & 2027 (%)
53. GCC Plasma Fractionation Market, 2015 - 2027(USD Billion)
54. South Africa Plasma Fractionation Market, 2015 - 2027(USD Billion)
55. Rest Of Middle East & Africa Plasma Fractionation Market, 2015 - 2027(USD Billion)
56. South America Plasma Fractionation Market, 2015 - 2027(USD Billion)
57. Brazil Plasma Fractionation Market, 2015 - 2027(USD Billion)
58. Mexico Plasma Fractionation Market, 2015 - 2027(USD Billion)
59. Argentina Plasma Fractionation Market, 2015 - 2027(USD Billion)
60. Rest Of South America Plasma Fractionation Market, 2015 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Plasma Fractionation Market, 2015-2027 (USD Billion)
4. Plasma Fractionation requirement, by country, 2015-2027, (USD Billion)
5. North America Plasma Fractionation Market, By Product, 2015-2027 (USD Billion)
6. North America Plasma Fractionation Market, By Application, 2015-2027 (USD Billion)
7. North America Plasma Fractionation Market, By End User, 2015-2027 (USD Billion)
8. Europe Plasma Fractionation Market, By Product, 2015-2027 (USD Billion)
9. Europe Plasma Fractionation Market, By Application, 2015-2027 (USD Billion)
10. Europe Plasma Fractionation Market, By End User, 2015-2027 (USD Billion)
11. Asia Pacific Plasma Fractionation Market, By Product, 2015-2027 (USD Billion)
12. Asia Pacific Plasma Fractionation Market, By Application, 2015-2027 (USD Billion)
13. Asia Pacific Plasma Fractionation Market, By End User, 2015-2027 (USD Billion)
14. Middle East & Africa Plasma Fractionation Market, By Product, 2015-2027 (USD Billion)
15. Middle East & Africa Plasma Fractionation Market, By Application, 2015-2027 (USD Billion)
16. Middle East & Africa Plasma Fractionation Market, By End User, 2015-2027 (USD Billion)
17. South America Plasma Fractionation Market, By Product, 2015-2027 (USD Billion)
18. South America Plasma Fractionation Market, By Application, 2015-2027 (USD Billion)
19. South America Plasma Fractionation Market, By End User, 2015-2027 (USD Billion)
20. Global Plasma Fractionation Market, Company Market Share, 2020 - 2027 (%)
21. Grifols: Product Benchmarking
22. Grifols: Financial Performance
23. Shire: Product Benchmarking
24. Shire: Financial Performance
25. Octapharma: Product Benchmarking
26. Octapharma: Financial Performance
27. Kedron: Product Benchmarking
28. Kedrion: Financial Performance
29. BPL: Product Benchmarking
30. BPL: Financial Performance
31. Sanquin: Product Benchmarking
32. Sanquin: Financial Performance
33. LFB: Product Benchmarking
34. LFB: Financial Performance
35. BIOTEST: Product Benchmarking
36. BIOTEST: Financial Performance
37. Japan Blood Products Organization: Product Benchmarking
38. Japan Blood Products Organization: Financial Performance
39. China Biologic Products: Product Benchmarking
40. China Biologic Products: Financial Performance
The Leading Key Players in Plasma Fractionation Market
CSL (Australia)
Grifols (Spain)
Shire (Ireland)
Octapharma (Switzerland)
Kedrion (Italy)
BPL (UK)
Sanquin (Netherlands)
LFB (France)
Biotest (Germany)
Japan Blood Products Organization
China Biologic Products (China)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China).
